Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G(2)/M arrest induced by topoisomerase II inhibitors

CD26/dipeptidyl peptidase IV (DPPIV) is a surface antigen with multiple functions, including a role in T-cell activation and the development of certain human cancers. We previously demonstrated that CD26/DPPIV enhanced sensitivity of Jurkat cells to doxorubicin. We now show that expression of CD26/D...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Aytac, U, Sato, K, Yamochi, T, Ohnuma, K, Mills, G B, Morimoto, C, Dang, N H
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2003
Aiheet:
Experimental Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2747550/
https://ncbi.nlm.nih.gov/pubmed/12569391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600791
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia